NASDAQ · VEEV
Healthcare · Medical - Healthcare Information Services
$312.96
Down-$4.68 (-1.50%)
Updated Nov 2, 2026, 8:28 PM
SID Score
6.8/10
Composite research score
Smart Money
58/100
Neutral
Price performance · VEEV
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
VEEV closed at $312.96 after 20 trading sessions, up 10.41% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $312.06 | $314.4999 | $309.42 | $312.96 | 1.38M |
| Oct 29, 2026 | $312.11 | $315.235 | $306.50 | $310.34 | 1.79M |
| Oct 28, 2026 | $310.00 | $319.00 | $308.50 | $317.82 | 1.4M |
| Oct 27, 2026 | $315.50 | $318.51 | $310.50 | $313.46 | 1.36M |
| Oct 26, 2026 | $323.04 | $325.87 | $316.91 | $318.18 | 1.12M |
| Oct 23, 2026 | $320.67 | $324.76 | $319.00 | $323.04 | 1.37M |
| Oct 22, 2026 | $323.99 | $325.99 | $318.03 | $322.55 | 1.44M |
| Oct 21, 2026 | $317.01 | $322.99 | $316.075 | $320.55 | 1.43M |
| Oct 20, 2026 | $318.00 | $322.00 | $310.38 | $318.67 | 1.81M |
| Oct 19, 2026 | $310.33 | $318.28 | $310.33 | $316.80 | 1.38M |
| Oct 16, 2026 | $319.95 | $319.95 | $306.575 | $310.36 | 1.73M |
| Oct 15, 2026 | $295.67 | $315.02 | $295.67 | $313.03 | 2.87M |
| Oct 14, 2026 | $300.14 | $301.50 | $293.66 | $297.35 | 1.24M |
| Oct 13, 2026 | $300.00 | $309.3195 | $299.895 | $301.63 | 2.25M |
| Oct 12, 2026 | $296.53 | $300.63 | $293.665 | $295.85 | 1.14M |
| Oct 9, 2026 | $285.71 | $297.45 | $284.00 | $296.13 | 1.85M |
| Oct 8, 2026 | $282.13 | $285.245 | $279.0201 | $284.84 | 922.1K |
| Oct 7, 2026 | $284.23 | $286.98 | $279.795 | $282.50 | 1.12M |
| Oct 6, 2026 | $285.34 | $289.87 | $282.2628 | $283.50 | 1.17M |
| Oct 5, 2026 | $275.00 | $283.47 | $274.00 | $283.45 | 1.32M |
The latest Smart Investors Daily articles mentioning VEEV.
Company
Market Activity
Research & News
VEEV research
Company profile and research snapshot.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 28, 2026 | Barclays | Overweight | — |
| Oct 26, 2026 | Baird | Outperform | — |
| Oct 19, 2026 | Barclays | Overweight | — |
| Aug 28, 2026 | Citigroup | Neutral | — |
| Aug 27, 2026 | UBS | Neutral | — |
No generated briefing is available yet.
Benzinga · Oct 30, 2026
Veeva Systems (NYSE:VEEV) has outperformed the market over the past 10 years by 9.82% on an annualized basis producing an average annual return of 23.58%. Currently, Veeva Systems has a market capitalization of $50.25
Yahoo · Oct 30, 2026
Veeva Systems has delivered a 63.4% gain over the past three years, and after a strong run into 2026 the obvious question is whether that kind of share price performance is still grounded in the cash the business can generate. With the stock around US$310, investors now have to ask if the current valuation is fully explained by its future cash flows or if expectations have started to run ahead of themselves. A 63.4% return over three years puts a lot of weight on Veeva Systems to keep...
Yahoo · Oct 29, 2026
Veeva Systems (VEEV) moves back into focus as investors look ahead to fiscal Q3 2027 results, with analysts projecting EPS of $1.68 and highlighting momentum in AI driven CRM adoption. Recent trading tells a story of rebuilding confidence in Veeva Systems. The share price is up 13.52% over the past 30 days and 57.68% across 90 days, while the 3-year total shareholder return of 69.91% contrasts with a flat 5-year total shareholder return. This suggests that momentum has picked up again after a...
Yahoo · Oct 29, 2026
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning VEEV.
